Soft tissue necrosis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:29:28 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Soft tissue necrosis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Evaluating Hyperbaric Oxygen Treatment in Addition to Standard Care for Patients with Necrotizing Soft-Tissue Infection https://clinicaltrials.eu/trial/evaluating-hyperbaric-oxygen-treatment-in-addition-to-standard-care-for-patients-with-necrotizing-soft-tissue-infection/ Wed, 29 Apr 2026 15:06:53 +0000 https://clinicaltrials.eu/trial/evaluating-hyperbaric-oxygen-treatment-in-addition-to-standard-care-for-patients-with-necrotizing-soft-tissue-infection/ This study focuses on Necrotizing Soft-Tissue Infection, a severe condition where bacteria cause tissue death under the skin. The research evaluates the effectiveness of Hyperbaric Oxygen treatment, which involves breathing pure oxygen in a special pressurized chamber, as an additional therapy alongside standard medical care.

The treatment being tested uses Medical Liquid Oxygen administered through inhalation in specialized chambers. Patients may receive up to two treatments per day for a maximum of four days. This therapy is given in addition to the usual medical care that all patients with this infection normally receive.

The main goal of this research is to determine if adding hyperbaric oxygen therapy to standard treatment helps improve survival rates in people with necrotizing soft-tissue infection. The study will monitor patients’ progress and overall health outcomes to evaluate how well this additional treatment works compared to standard care alone.

]]>